VeriMomVeriMom

resorcinol은 임신 중 안전한가요?

SCCS (EU Scientific Committee on Consumer Safety) identified endocrine‑disrupting/thyroid effects for resorcinol and set restricted safe use levels in cosmetics, indicating suspected reproductive/endocrine hazards though used at low concentrations (SCCS opinion). Animal toxicology (NTP/NIH gavage studies) shows systemic effects at higher doses including thyroid and other systemic toxicity, supporting a mechanistic concern. Topical cosmetic use can give low but measurable systemic exposure at typical consumer concentrations, so exposure is rated as low/measurable. ([health.ec.europa.eu](https://health.ec.europa.eu/publications/resorcinol_en?utm_source=openai))

성분
resorcinol
중간 위험
40
/100
0

임신 중 resorcinol 대체 안전 성분 | VeriMom

Related ingredients

Frequently asked questions

resorcinol은 임신 중 안전한가요?
SCCS (EU Scientific Committee on Consumer Safety) identified endocrine‑disrupting/thyroid effects for resorcinol and set restricted safe use levels in cosmetics, indicating suspected reproductive/endocrine hazards though used at low concentrations (SCCS opinion). Animal toxicology (NTP/NIH gavage studies) shows systemic effects at higher doses including thyroid and other systemic toxicity, supporting a mechanistic concern. Topical cosmetic use can give low but measurable systemic exposure at typical consumer concentrations, so exposure is rated as low/measurable. ([health.ec.europa.eu](https://health.ec.europa.eu/publications/resorcinol_en?utm_source=openai))
resorcinol은 모유 수유 중 안전한가요?
Same basis as pregnancy: mechanistic evidence for endocrine/thyroid activity (SCCS; toxicology studies) gives a suspected reproductive/endocrine hazard. For topical cosmetic use systemic exposure is expected to be low but measurable; therefore breastfeeding exposure risk is rated similarly. There are no strong human lactation transfer data specific to resorcinol in cosmetics. ([health.ec.europa.eu](https://health.ec.europa.eu/publications/resorcinol_en?utm_source=openai))
resorcinol은 아기 피부에 안전한가요?
Hazard and mechanism scores follow the SCCS/toxicology evidence (suspected endocrine/thyroid effects). Exposure for infants (0–3 yr) is increased by +1 relative to adults because immature skin and higher surface‑area:weight raise potential per‑kg uptake from topical products; thus exposure is moderate. No infant‑specific dermal toxicity studies were identified. ([health.ec.europa.eu](https://health.ec.europa.eu/publications/resorcinol_en?utm_source=openai))
VeriMom은 resorcinol을 어떻게 평가하나요?
VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 resorcinol을 40/100 (중간 위험)로 평가합니다.
임신 중 resorcinol 대체 안전 성분은?
유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.

모든 성분표를 2초 만에 확인

VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.

의료 면책 조항

이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.

VeriMom 앱에서 모든 기능을 이용해 보세요